Dr. Yuelei Shen, Chairman & CEO
1988-1992, B.A., Virology and Molecular Biology, Wuhan University
1992-1995, M.S., National Institutes for Food and Drug Control
1997-2003, Ph.D., University of Massachusetts School of Medicine
2003-2008, Post Doctorate, New York University School of Medicine
2008.6, Founded Biocytogen Biotechnology Company in United States
2009.11, Founded Beijing Biocytogen Co., Ltd.
2011.4, Awarded the fourth batch of Beijing “sea poly” talents
2013.10, Included in the Thousand Talents Program
2014.4, Honored as one Beijing’s 100 science and technology leading talents
2014.12, Awarded "National Excellent Scientist"
2015.7, Elected as the director of the Chong Kai Future International Youth Science and Technology Entrepreneurship Competition
Dr. Yuelei Shen has nearly 20 years of experience in immunology, molecular biology and gene knockout model animal production and research, and has mainly investigated the pathological mechanisms involved in autoimmune disease using mouse models. He has produced several gene knockout/knockin mouse strains that are used by hundreds of labs worldwide, and these studies have been published in top journals such as Nature, Nature Immunology, and Immunity.
Dr. Chaoshe Guo, Vice President of Marketing
1989-1994, B.A., Clinical Medicine, Henan Medical University
1994-1996, Assistant Professor, Department of Pharmacology, Henan Medical University
1996-1999, M.S., Peking Union Medical University (Chinese Academy of Medical Sciences)
2000-2003, Ph.D., Max Planck Institute for Biophysical Chemistry and Georg-August-University of Göttingen.
Dr. Guo received a doctoral degree in Biochemistry in November, 2003, where he worked on the functional study of molecular chaperones via biochemistry, structural biology, and gene knockout mouse models.
In 2005-2013, Dr. Guo has focused on Hedgehog signaling and its role in cardiovascular system and blood system development through his joint appointment in the Department of Molecular and Cellular Biology at Harvard University and Boston Children's Hospital/Harvard Medical School. His research has been published in JCI, Development, and other highly reputed journals. Dr. Guo is also experienced in animal model production and phenotype analysis.
In October, 2013, Dr. Guo served as the Senior R&D Director and Key Account Manager of Beijing Biocytogen Co., Ltd, and also served as the Vice President of Marketing in June, 2015.
Dr. Tianquan Jin, Vice President of Biocytogen, U.S.
1988-1992, B.A., Virology and Molecular Biology, Wuhan University.
1992-1998, Ph.D., Virology, Wuhan University；
1999-2010, Post Doctorate and Research Assistant Professor, University of Illinois at Chicago
2010-2011, Advanced Cell Technology (ACT), worked on human embryonic stem cell research.
2011.11, joined Biocytogen, U.S. as Vice President.